“ Therapy for HER2-positive gastric cancer: an overview of the molecular and genetic characteristics of the signaling pathway, the results of clinical trials”. (2023) Voprosy onkologii, 69(1), pp. 45–54. doi:10.37469/0507-3758-2023-69-1-45-54.